| Manorcare Health Services-fair Oaks | |
| 12475 Lee Jackson Memorial Highway, Fairfax, Virginia 22033 | |
| (703) 352-7172 | |
| Name | Manorcare Health Services-fair Oaks |
|---|---|
| Location | 12475 Lee Jackson Memorial Highway, Fairfax, Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 155 |
| Occupancy Rate | 80.77% |
| Medicare ID (CCN) | 495217 |
| Legal Business Name | Manor Care-fair Oaks Of Fairfax Va Llc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1861437154 |
| Organization Name | MANOR CARE-FAIR OAKS OF FAIRFAX VA LLC |
| Doing Business As | PROMEDICA SKILLED NURSING AND REHABILITATION (FAIR OAKS) |
| Address | 12475 Lee Jackson Memorial Hwy, Fairfax, VA 22033 |
| Phone Number | 703-352-7172 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics SA, a leading medical diagnostic company in Europe, as its exclusive distributor of Signature® Oncology Products in France. Asuragen's Signature Oncology Portfolio comprises multiplex assays for the detection of mutations in solid and hematologic malignancies.
Deaths from stomach cancer are the lowest since UK records began nearly 40 years ago, according to new Cancer Research UK figures released today (Thursday).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
Arcomed AG, a global provider of IV pumps, and Capsule, the leading provider of medical device connectivity, today announced an agreement that promotes connectivity between Arcomed's IV pumps and hospital information systems using Capsule's leading vendor neutral connectivity solution.
Pharmacists given an expanded role in patient oversight can reduce the likelihood of high-risk patients returning to the hospital, according to a new study that underscores a potential cost-saving solution for a growing physician shortage.
› Verified 9 days ago
| NPI Number | 1972214393 |
| Organization Name | FAIR OAKS SNF OPERATIONS LLC |
| Address | 12475 Lee Jackson Memorial Hwy, Fairfax, VA 22033 |
| Phone Number | 703-352-7172 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics SA, a leading medical diagnostic company in Europe, as its exclusive distributor of Signature® Oncology Products in France. Asuragen's Signature Oncology Portfolio comprises multiplex assays for the detection of mutations in solid and hematologic malignancies.
Deaths from stomach cancer are the lowest since UK records began nearly 40 years ago, according to new Cancer Research UK figures released today (Thursday).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
Arcomed AG, a global provider of IV pumps, and Capsule, the leading provider of medical device connectivity, today announced an agreement that promotes connectivity between Arcomed's IV pumps and hospital information systems using Capsule's leading vendor neutral connectivity solution.
Pharmacists given an expanded role in patient oversight can reduce the likelihood of high-risk patients returning to the hospital, according to a new study that underscores a potential cost-saving solution for a growing physician shortage.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics SA, a leading medical diagnostic company in Europe, as its exclusive distributor of Signature® Oncology Products in France. Asuragen's Signature Oncology Portfolio comprises multiplex assays for the detection of mutations in solid and hematologic malignancies.
Deaths from stomach cancer are the lowest since UK records began nearly 40 years ago, according to new Cancer Research UK figures released today (Thursday).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
Arcomed AG, a global provider of IV pumps, and Capsule, the leading provider of medical device connectivity, today announced an agreement that promotes connectivity between Arcomed's IV pumps and hospital information systems using Capsule's leading vendor neutral connectivity solution.
Pharmacists given an expanded role in patient oversight can reduce the likelihood of high-risk patients returning to the hospital, according to a new study that underscores a potential cost-saving solution for a growing physician shortage.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 9 |
| Total Amount of Fines in Dollars | $26325 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 9 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 12.62 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.38 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 67.92 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.52 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.63 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.54 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.18 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.36 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.59 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.12 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 29.12 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.56 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.84 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.76 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.21 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.98 | 82.93 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics SA, a leading medical diagnostic company in Europe, as its exclusive distributor of Signature® Oncology Products in France. Asuragen's Signature Oncology Portfolio comprises multiplex assays for the detection of mutations in solid and hematologic malignancies.
Deaths from stomach cancer are the lowest since UK records began nearly 40 years ago, according to new Cancer Research UK figures released today (Thursday).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
Arcomed AG, a global provider of IV pumps, and Capsule, the leading provider of medical device connectivity, today announced an agreement that promotes connectivity between Arcomed's IV pumps and hospital information systems using Capsule's leading vendor neutral connectivity solution.
Pharmacists given an expanded role in patient oversight can reduce the likelihood of high-risk patients returning to the hospital, according to a new study that underscores a potential cost-saving solution for a growing physician shortage.
› Verified 9 days ago
Fairfax Rehabilitation And Nursing Center Location: 10701 Main Street, Fairfax, Virginia 22030 Phone: (703) 273-7705 | |
Manorcare Health Services-fair Oaks Location: 12475 Lee Jackson Memorial Highway, Fairfax, Virginia 22033 Phone: (703) 352-7172 | |